Eimskip announces Q2 2014 financial results Operating

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Eimskip announces Q2 2014 financial results
  • Operating revenue EUR 109.0 million, up by EUR 0.9 million from Q2 2013
  • Operating profit, EBITDA, EUR 11.0 million, up by EUR 1.2 million from Q2 2013
  • Net earnings EUR 4.6 million, up by EUR 2.6 million from Q2 2013
  • Transported volume in North Atlantic liner services up by 7.1% from Q2 2013
  • Transported volume in reefer forwarding services up by 4.9% from Q2 2013
  • Equity ratio was 65.4% and net debt was EUR 32.0 million at the end of June
  • Forecasted EBITDA for the year 2014 unchanged, in the range of EUR 37 to 41 million

Gylfi Sigfússon, President and CEO

“The operational results of the second quarter are in line with our expectations. The company’s revenues for the quarter amounted to EUR 109.0 million compared to EUR 108.1 million for the same period last year. EBITDA for the second quarter grew by 12.3% from previous year and amounted to EUR 11.0 million. The increased EBITDA is, among other, explained by increased transported volume and more efficient sailing system following the changes made on the Red Line route and by adding the Gray Line in the first quarter this year. Net earnings for the period more than doubled from last year, amounted to EUR 4.6 million and grew by EUR 2.6 million from the second quarter 2013, mainly due to currency movements.

Revenues for the first six months were flat with last year, in the amount of EUR 213.2 million. EBITDA for the first six months remained the same as last year, or EUR 17.1 million. Transported volume in the company’s North Atlantic liner services for the first six months increased by 9.1% from the same period last year. Imported volume to Iceland has been growing this year and it is constructive to see a positive trend in categories such as vehicles and construction supplies after stagnation in recent years. Transported volume in the company’s reefer forwarding services rose by 9.2% from the same period last year, mainly due to increased activity in inbound cargo. Inbound means that Eimskip takes care of custom clearance and door-to-door delivery of the cargo.

The 875 TEU container vessel Lagarfoss, the first of the two container vessels being built for Eimskip in China, was delivered in China on 24 June. The vessel, which arrived in Reykjavik on 17 August, is already in service and will replace Selfoss on the Yellow Line. The Lagarfoss will increase the line’s capacity by 151 TEU, besides being a faster, more cost-efficient per TEU and more environmentally friendly vessel. The Selfoss will replace the chartered vessel Horst B on the Red Line in September. These vessel fleet changes are expected to increase the company’s current EBITDA by 2-3% on a yearly basis. The Lagarfoss will increase the service reliability, which is extremely important for export of seafood from Iceland and the Faroe Islands to the UK and mainland Europe. The delivery of the Lagarfoss also gives an opportunity of adding new ports of call in order to increase services to our customers. We are very proud to finally have the Lagarfoss in operations.

It has been decided to complete negotiations of finishing the building of Bakkafoss, the sister vessel of the Lagarfoss. The shipyard has offered further discount of the vessel’s purchase price in the amount of USD 0.8 million and the estimated delivery is in the fourth quarter 2015. After the negotiated discount, the total contract price for the second vessel will be USD 18.0 million.

There is still uncertainty in the labor market in Iceland and the company has open agreements with a part of the Icelandic crew members of its container vessels and the ferry Herjólfur. There is also some uncertainty in international markets, especially regarding Russia’s food import restrictions which took place now in August. It is still uncertain how the sanctions will hit Eimskip’s operations, but they are expected to affect the transport of seafood from Newfoundland and Norway to Russia. Iceland is not included in the Russian embargo.

Regarding the investigation of the Icelandic Competition Authority, Eimskip is still, without success, seeking information on its subject matter to get a better understanding of the investigation. The company decided to appeal to the Competition Appeals Committee following the Icelandic Competition Authority’s gathering of further information in June this year. The company is waiting for the second ruling of the Competition Appeals Committee.

Eimskip continues to evaluate its external growth opportunities to strengthen its current position in markets outside Iceland and in line with the company’s vision of being a leading transportation company in the North Atlantic. The company continues working on preparing the dual listing of its shares in relation to these potential investments.

We keep our EBITDA forecast for the year 2014 unchanged in the range of EUR 37 to 41 million.”

Further information

  • Gylfi Sigfússon, President and CEO, tel.: +354 525 7202
  • Hilmar Pétur Valgardsson, CFO,  tel.: +354 525 7202
  • Erna Eiríksdóttir, Senior Manager of Investor Relations, tel.: +354 825 7220, email: investors@eimskip.is
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 246

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 694

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 180

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

HD Hyundai Sparks Fusion Hopes with ITER Milestone

Updated Category News Views 9

Hold on to Your Hard Hats, Fusion Milestone Achieved Look who's making waves in the world of nuclear fusion. HD Hyundai Heavy Industries has hit a crucial benchmark in the ITER nuclear fusion project. This ain't your run-of-the-mill accomplishment, folks. We're talking about completing the assembly of some of the most complex and intricately designed machinery known to...

Continue Reading
ChemoMetec Boosts Financial Outlook with Anticipated Growth

Updated Category News Views 353

ChemoMetec Boosts Financial Outlook Amid Growing Interest ChemoMetec is excited to announce an upgrade in its financial guidance as the company sees a growing demand for its pioneering technologies, particularly the highly regarded XcytoMatic platform. This surge in interest bodes well for the company's revenue and profit, reflecting a positive trajectory as it approaches...

Continue Reading
GDS Holdings Completes Successful C-REIT IPO on Shanghai Exchange

Updated Category News Views 200

GDS Holdings Limited Celebrates C-REIT IPO Success GDS Holdings Limited, known as GDS, is thrilled to announce that it has successfully completed its initial public offering of its China REIT, or C-REIT, on the Shanghai Stock Exchange. This milestone marks an exciting moment for the company and its stakeholders as market interest surpassed expectations. Highlighting the...

Continue Reading
Innovative E-Waste Solutions from Techbros Redefine Recycling

Updated Category News Views 273

AI-Driven E-Waste Innovation from Techbros In a remarkable leap towards sustainability and innovative technology, Techbros Electronic Recycling proudly announces the launch of the Southwest's first fully integrated AI-driven IT asset disposition (ITAD) and e-waste processing facility. This state-of-the-art facility exemplifies the future of electronics recycling by...

Continue Reading
SageSure Welcomes Insurance Veteran Peter Hearn to Board

Updated Category News Views 268

SageSure Welcomes New Board Member SageSure, one of the largest managing general underwriters that focus on markets exposed to catastrophe risks, has taken a significant step by appointing Peter Hearn to its Board of Managers. This strategic move is anticipated to bolster the company’s leadership and industry insights. Peter Hearn's Impressive Background Peter Hearn...

Continue Reading